Draft:Haileyesus Getahun

Haileyesus Getahun is an Ethiopian global health expert, researcher, and advocate. He is currently the Chief Executive Officer of HeDPAC, an organization dedicated to strengthening south-to-south partnerships in health development. Before this role, he served at the WHO headquarters in Geneva from 2003 to 2024, where he led numerous public health initiatives.

Early Life and Education
Getahun graduated from Addis Ababa University Medical Faculty as a medical doctor. He obtained a Master's in Public Health degree from the Free University of Brussels and a PhD in epidemiology and public health degree from the Institute of Tropical Medicine Antwerp and Ghent University, Belgium.

Public Health Career in Ethiopia
Getahun began his career as a general practitioner at Estie Health Center in the Amhara region of Ethiopia. He conducted numerous operational and implementation research on neurolathyrism, tuberculosis, and reproductive health while managing the health center and later the zonal health programs department in South Gonder. His rural based research work and publications led to him becoming the first recipient of the Young Public Health Researcher award of Ethiopia in 1999.

Tuberculosis (TB) Research and Programs
Getahun initiated the TB club approach, which empowered communities and improved TB control services in the Estie District and other areas of the Amhara region between 1995 and 1998. This initiative was recognized by the WHO as an initiative to engage communities in TB control activities and replicated in countries such as Nicaragua, India, Mongolia, and Mexico.

Neurolathyrism Research
Getahun was a notable public health researcher in neurolathyrism who investigated and reported the epidemic that occurred in northern Ethiopia in 1997-99. He later conducted a longitudinal ecological study and defined preventive measures for neurolathyrism.

Reproductive and sexual health research
Getahun served as a youth program manager and principal investigator at the Family Guidance Association of Ethiopia, where he introduced emergency contraception in eight youth centers across the country.

Global Health Career at WHO
Getahun joined the WHO in 2003 to work on HIV related TB. Over his tenure, he expanded his scope to various public health areas until his appointment as CEO of HeDPAC in April 2024.

TB and HIV Work at WHO
Getahun led the development of the first interim TB/HIV policy in 2004, resulting in comprehensive guidelines by 2012. His Lancet publication and work on diagnosing smear-negative TB among HIV-positive individuals had a significant impact on subsequent policy changes and TB care. As the principal investigator of a study published in PLoS Medicine, Getahun's work led to the WHO four-symptom screening for TB, enhancing care for HIV-positive individuals. His publication in the New England Journal of Medicine broadened the focus of TB prevention and led to global policy changes. He collaborated with HIV activist Mark Harrington (HIV/AIDS activist) to introduce and foster patient and community activism in the global TB response, mentoring numerous activists from Africa, Asia and Latin America who became key global advocates.

Antimicrobial Resistance Work at WHO
Getahun became the Director of the UN Interagency Coordinating Group (IACG) Secretariat on AMR, established following the 2016 UN General Assembly Political Declaration on AMR. He was the coordinator of the Secretariat and the lead author of the IACG Report, which was submitted to the UN Secretary General. Getahun was also the founding director of the Quadripartite Joint Secretariat on AMR, facilitating inter-agency coordination among the Food and Agriculture Organization of the United Nations (FAO), the United Nations Environment Programme (UNEP),the World Health Organization (WHO), and the World Organisation for Animal Health (WOAH). He led the establishment of the Global Leaders Group on Antimicrobial Resistance in November 2020 and coordinated its work until April 2024. He advocates for antibiotics to be considered as a global public goods and for setting up global targets and financing mechanism for AMR.